Cargando…

Cell Therapies for Parkinson's Disease

Detalles Bibliográficos
Autor principal:	Irion, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440559/ https://www.ncbi.nlm.nih.gov/pubmed/30771274 http://dx.doi.org/10.1111/cts.12612

Ejemplares similares

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

Potential role of biofeedback therapy for Parkinson’s disease
por: Kotani, Naoya, et al.
Publicado: (2021)

Targeting chaperone-mediated autophagy for Parkinson’s disease therapy
por: Wang, Yi-Ting, et al.
Publicado: (2023)

Science communication: a career where PhDs can make a difference
por: Irion, Robert
Publicado: (2015)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Real world studies are essential for drug therapy in Parkinson’s disease
por: Müller, Thomas
Publicado: (2018)

Gene therapy in Parkinson's disease: targeting the endplasmic reticulum proteostasis network
por: Castillo, Valentina, et al.
Publicado: (2015)

Why and how does light therapy offer neuroprotection in Parkinson's disease?
por: Mitrofanis, John
Publicado: (2017)

Cell replacement for Parkinson’s disease: advances and challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Developmental genetics with model organisms
por: Irion, Uwe, et al.
Publicado: (2022)

Alpha-synuclein preformed fibrils: a tool to understand Parkinson’s disease and develop disease modifying therapy
por: Chmielarz, Piotr, et al.
Publicado: (2021)

Mitochondria in the context of Parkinson's disease
por: Villacé, Patricia, et al.
Publicado: (2017)

Falling upward with Parkinson’s disease
por: Buetow, Stephen A., et al.
Publicado: (2017)

Stem Cell Transplantation for Parkinson’s Disease: Current Challenges and Perspectives
por: Zeng, Xinlin, et al.
Publicado: (2022)

The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease
por: Padmanabhan, Shalini, et al.
Publicado: (2020)

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
por: Sulzer, David, et al.
Publicado: (2020)

Novel pluripotent stem cell lines for enriched grafting in Parkinson’s disease
por: Cota-Coronado, Agustin, et al.
Publicado: (2019)

The paradigm of protein acetylation in Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2019)

Genetic Analysis of Pathways to Parkinson Disease
por: Hardy, John
Publicado: (2010)

Parkinson’s disease-associated melanin steal
por: Hinz, Marty, et al.
Publicado: (2014)

Parkinson’s disease: carbidopa, nausea, and dyskinesia
por: Hinz, Marty, et al.
Publicado: (2014)

Efficacy of cognitive rehabilitation in Parkinson's disease
por: Díez-Cirarda, María, et al.
Publicado: (2018)

The role of viruses in the pathogenesis of Parkinson’s disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2020)

Gene therapy for Parkinson's disease: a decade of progress supported by posthumous contributions from volunteer subjects
por: Bartus, Raymond T.
Publicado: (2015)

Brain repair for Parkinson’s disease: is the answer in the matrix?
por: Moriarty, Niamh, et al.
Publicado: (2018)

The second brain in Parkinson’s disease: fact or fantasy?
por: Yemula, Nehal, et al.
Publicado: (2022)

Redefining the hypotheses driving Parkinson’s diseases research
por: Farrow, Sophie L., et al.
Publicado: (2022)

Wrapping up the role of pericytes in Parkinson’s disease
por: Stevenson, Taylor John, et al.
Publicado: (2023)

Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson’s Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study
por: Picca, Anna, et al.
Publicado: (2019)

Comparative efficacy of surgical approaches to disease modification in Parkinson disease
por: Rahimpour, Shervin, et al.
Publicado: (2022)

Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson’s disease?
por: Acharya, Shubhra, et al.
Publicado: (2021)

Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease
por: Yang, Huijia, et al.
Publicado: (2022)

Can cinnamon bring aroma in Parkinson's disease treatment?
por: Pahan, Priyanka, et al.
Publicado: (2015)

Rebound excitability mediates motor abnormalities in Parkinson’s disease
por: Kim, Jeongjin, et al.
Publicado: (2018)

Exploring the use of transcranial photobiomodulation in Parkinson's disease patients
por: Hamilton, Catherine, et al.
Publicado: (2018)

Mitochondrial homeostasis in Parkinson’s disease - a triumvirate rule?
por: Ng, Chee-Hoe, et al.
Publicado: (2017)

Short-chain fatty acids in the context of Parkinson’s disease
por: Metzdorf, Judith, et al.
Publicado: (2021)

The dual role of necrostatin-1 in Parkinson’s disease models
por: Alegre-Cortés, Eva, et al.
Publicado: (2021)

Vibrotactile coordinated reset stimulation for the treatment of Parkinson's disease
por: Tass, Peter A.
Publicado: (2021)

Parkinson’s Disease Etiology: Insights and Associations with Phosphate Toxicity
por: Brown, Ronald B.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p16v2f4oqn5m5o5gh3dkn0fr0m